CYTEK BIOSCIENCES, INC. Financing Cash Flow
CYTEK BIOSCIENCES, INC. (CTKB) reported Financing Cash Flow of $3.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$814.00K.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.98M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$1.23M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.94M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$13.43M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$15.82M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$41.81M, a 858.43% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2022 was $5.51M, a 97.42% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$814.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.17M 10-Q · filed 2026-08-05 | $1.94M derived: sum of 3 quarters · filed 2026-08-05 | $3.88M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.98M 10-Q · filed 2026-05-07 | $2.75M derived: sum of 2 quarters · filed 2026-05-07 | $4.70M derived: sum of 3 quarters · filed 2026-05-07 | $2.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $715.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.89M derived: sum of 3 quarters · filed 2026-08-05 | -$13.43M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$661.00K derived: sum of 2 quarters · filed 2026-08-05 | -$12.21M 10-Q · filed 2025-11-05 | -$15.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$14.15M 10-Q · filed 2026-08-05 | -$17.79M derived: sum of 3 quarters · filed 2026-08-05 | -$29.87M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$11.54M 10-Q · filed 2026-05-07 | -$15.19M derived: sum of 2 quarters · filed 2026-05-07 | -$27.27M derived: sum of 3 quarters · filed 2026-05-07 | -$28.98M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$15.72M derived: sum of 2 quarters · filed 2026-02-26 | -$17.43M derived: sum of 3 quarters · filed 2026-02-26 | -$15.82M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$12.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$13.79M derived: sum of 2 quarters · filed 2025-11-05 | -$12.18M 10-Q · filed 2025-11-05 | -$45.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$98.00K 10-Q · filed 2025-08-06 | -$33.85M derived: sum of 3 quarters · filed 2026-02-26 | -$42.13M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.61M 10-Q · filed 2025-05-08 | -$32.14M derived: sum of 2 quarters · filed 2026-02-26 | -$40.41M derived: sum of 3 quarters · filed 2026-02-26 | -$40.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$33.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$42.03M derived: sum of 2 quarters · filed 2026-02-26 | -$41.81M derived: sum of 3 quarters · filed 2026-02-26 | -$41.81M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$8.06M derived: sum of 2 quarters · filed 2024-11-07 | -$8.06M 10-Q · filed 2024-11-07 | -$4.21M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $216.00K 10-Q · filed 2024-08-06 | $4.07M derived: sum of 3 quarters · filed 2025-02-28 | $4.22M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $3.85M derived: sum of 2 quarters · filed 2025-02-28 | $4.00M derived: sum of 3 quarters · filed 2025-02-28 | $5.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.00M derived: sum of 2 quarters · filed 2025-02-28 | $5.15M derived: sum of 3 quarters · filed 2025-02-28 | $5.51M 10-K · filed 2025-02-28 |
| 2022-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.30M derived: sum of 2 quarters · filed 2023-11-14 | $1.66M 10-Q · filed 2023-11-14 | $1.68M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.51M 10-Q · filed 2023-08-08 | $1.52M derived: sum of 3 quarters · filed 2024-03-13 | $218.60M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $364.00K 10-Q · filed 2023-05-09 | $381.00K derived: sum of 2 quarters · filed 2024-03-13 | $217.46M derived: sum of 3 quarters · filed 2024-03-13 | $213.74M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $217.09M derived: sum of 2 quarters · filed 2024-03-13 | $213.37M derived: sum of 3 quarters · filed 2024-03-13 | $213.56M 10-K · filed 2024-03-13 |
| 2021-09-30 | $217.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $213.35M derived: sum of 2 quarters · filed 2022-11-09 | $213.54M 10-Q · filed 2022-11-09 | $333.27M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$3.54M 10-Q · filed 2022-08-10 | $116.19M derived: sum of 3 quarters · filed 2023-03-01 | $114.98M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $187.00K 10-Q · filed 2022-05-12 | $119.91M derived: sum of 2 quarters · filed 2023-03-01 | $118.70M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | $119.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $118.51M derived: sum of 2 quarters · filed 2023-03-01 | $122.61M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.88M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $4.09M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |